SCHEMBL3606175

SCHEMBL3606175

CCOC(=O)C(CC)C(=O)C1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 2/20 0.37
RECQL P46063 1/20 0.36
PPM1B O75688 1/20 0.35
PTPN1 P18031 1/20 0.35
PPP1CC P36873 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.34
LGMN Q99538 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23295632 0.88 L3MBTL1 (0.39) ALDH1A1LMNARAB9AMAPTGAA
SCHEMBL3603382 0.87 PPM1B (0.38) ALDH1A1LMNAHPGDTSHRPPM1B
SCHEMBL3611663 0.87 HTT (0.34) ALDH1A1LMNARAB9AMAPTHPGD
SCHEMBL3609381 0.86 PIK3CD (0.36) ALDH1A1RAB9ATSHRCYP3A4CYP2C19
SCHEMBL3605651 0.84 SMN1; SMN2 (0.43) ALDH1A1LMNARAB9AMAPTHPGD
SCHEMBL3599574 0.84 SMN1; SMN2 (0.35) ALDH1A1TSHRCYP3A4CYP2C19GAA
SCHEMBL28054242 0.83 ALDH1A1 (0.46) ALDH1A1HPGDKMT2ANPSR1TSHR
SCHEMBL3589754 0.83 RECQL (0.38) ALDH1A1KMT2ATSHRRECQL
SCHEMBL3605660 0.81 CYP3A4 (0.42) ALDH1A1LMNARAB9AMAPTHPGD
SCHEMBL20138944 0.80 ALDH1A1 (0.41) ALDH1A1LMNARAB9AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741497-B2 Processes for preparing alkyl 3-(4-tetrahydropyranyl)-3-oxopropanoate compound and 4-acyltetrahydropyrane UBE INDUSTRIES, LTD. (JP) 2010-06-22 US disclosed
US-20070043107-A1 Processes for preparing alkyl 3-(4-tetrahydropyranyl)-3-oxopropanoate compound and 4-acyltetrahydropyrane UBE INDUSTRIES, LTD. (JP) 2007-02-22 US disclosed
EP-1700852-A1 PROCESSES FOR PRODUCING ALKYL 3-(4-TETRAHYDROPYRANYL)-3-OXOPROPIONATE COMPOUND AND 4-ACYLTETRAHYDROPYRAN Ube Industries, Ltd. (JP) 2006-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043107-A1 Processes for preparing alkyl 3-(4-tetrahydropyranyl)-3-oxopropanoate compound and 4-acyltetrahydropyrane DHPS, OXER1, CYP4A11 ALDH1A1 312/4885LMNA 3899/4885RAB9A 3231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.